Invrep Logo Website

In March 2014, Invrep successfully raised £150,000 to accelerate development of its reporting platform.

The Story

Software-provider Invrep (now Reportally) has come up with an innovative solution that takes the pain out of creating and maintaining an effective reporting framework. Invrep provides a professional environment for companies to interact with their stakeholders.

Invrep is headed up by Stephen Findlay, who has 12 years’ VC experience, and is a trained chartered accountant and self-taught programmer. The round was led by Robert Mason, an investor with more than 35 years of investment experience, and Roger Mercer, a serial angel investor.

33.9reportally

Where are they now?

Invrep has recently rebranded and is now Reportally - take a look at their new look website www.reportally.com

Reportally has rebranded as BondMason, launching its P2P SIPP product in April 2017. Read more about this development.

See current opportunities

Natural Immune Products

EIS
FMCG
Natural Immune Products producers of 100% natural, immunity-strengthening drinks for children.

Active

Trading status

£21,619

Average investment

£172,949

Total raised

Radio Physics Solutions

EIS
Technology, Hardware & Equipment
Radio Physics Solutions, the company determined to make the world a safer place, has successfully raised £700k from a number of business angels and sophisticated investors on SyndicateRoom.

Active

Trading status

£17,949

Average investment

£700,000

Total raised

Highview Power Storage

EIS
Property
Highview balances energy production and requirements by storing excess, off-peak energy and selling it to electricity networks at times of peak demand.

Active

Trading status

£15,672

Average investment

£767,950

Total raised

Bactest

EIS
Pharmaceuticals & Biotechnology
Bactest’s technology turns microbial activity into data, offering multiple industry applications. They raised £838,380.

Dissolved

Trading status

£13,478

Average investment

£930,000

Total raised

Apta Biosciences

EIS
Pharmaceuticals & Biotechnology
Apta Biosciences – creators of a groundbreaking alternative to antibodies – came to SyndicateRoom for help closing their £1.55 million round. The spin-off from Japanese IT giant Fujitsu wound up breezing past their funding target, closing at an impressive £1,792,500.

Active

Trading status

£34,906

Average investment

£1,850,000

Total raised

Pulsar

EIS
Technology, Hardware & Equipment
“Making the world a brighter place, one LED at a time”, Pulsar specialises in providing long-lasting lighting where light failure would be highly visible, or light replacement is complex, dangerous or costly to remedy (e.g. high rise buildings, bridges, etc.)

Insolvency Proceedings

Trading status

£22,076

Average investment

£618,120

Total raised